Fluorescence in situ hybridization-based confirmation of acute graft-vs-host disease diagnosis following liver transplantation: A case report

Table 2 Clinical manifestation and treatment timeline

	Manifestations				Drugs
PO day	Temperature (°C)	Skin rash	Diarrhea	Myelosuppression	Tacrolimus (mg/d)	MMF (g/d)	MP	IgG (g/d)	Antibiotics
22	38.3	Palm	2	NA	3	0.25	500	10	Yes
24	38.6	Neck	3	NA	2	0	500	10	Yes
26	38.5	Face	6	Yes	2	0	120	NA	Yes
28	38.2	Trunk	7	Yes	2	0	40	NA	Yes
30	39	> 35%	6	Yes	2	0	20	NA	Yes
32	38.6	> 50%	5	Yes	1.5	0	20	10	Yes
34	38.7	> 55%	4	Yes	1.5	0	20	10	NA
36	Demise

PO: Post-operative; NA: Not applicable; MMF: Two oral formulations of mycophenolate mofetil; MP: Methylprednisolone; IgG: Immunoglobulin G. Antibiotics: Melophenan (1 g every 8 h) + carpophennet (50 mg per day) + vancomycin (0.5 g every 6 h).